Colorectal cancer (CRC) is one of the most common malignant carcinomas. CRC is
characterized by asymptomatic onset, and most patients are already in the middle and …

Colorectal carcinoma (CRC) is one of the most frequently diagnosed carcinomas and one of
the leading causes of cancer-related death worldwide. Metabolic reprogramming, a hallmark …

Accumulating evidence from studies in humans and animal models has elucidated that gut
microbiota, acting as a complex ecosystem, contributes critically to colorectal cancer (CRC) …

Colorectal cancer (CRC) is one of the most frequent tumor entities worldwide with only
limited therapeutic options. CRC is not only a genetic disease with several mutations in …

Regulatory T cells (Treg), as members of CD4+ T cells, have garnered extensive attention in
the research of tumor progression. Treg cells have the function of inhibiting the immune …

The gut microbiota is currently considered an external organ of the human body that
provides important mechanisms of metabolic regulation and protection. The gut microbiota …

Colorectal cancer (CRC) is the third most common cancer in the world. Although there are
standard treatment options for CRC, most patients respond poorly to these treatments …

Tumor immune microenvironment (TIME), a tumor-derived immune component, is proven to
be closely related to the development, metastasis, and recurrence of tumors. Gut microbiota …

Colorectal cancer (CRC) is one of the leading causes of cancer-related death in the world.
Besides genetic causes, colonic inflammation is one of the major risk factors for CRC …

Finding new therapeutic approaches towards colorectal cancer (CRC) is of increased
relevance, as CRC is one of the most common cancers worldwide. CRC standard therapy …